Literature DB >> 12441700

Antenatal corticosteroids: the good, the bad and the unknown.

John P Newnham1, Timothy J M Moss, Ilias Nitsos, Deborah M Sloboda.   

Abstract

PURPOSE OF REVIEW: The purpose of this review was to summarize recently published clinical and animal-based studies of antenatal corticosteroids, describe current recommendations for practice, and suggest priority areas for future research. RECENT
FINDINGS: A single course of antenatal corticosteroids is known to improve newborn lung function after preterm birth and to reduce the risk of newborn death. Current evidence from animal and clinical studies suggests that additional numbers of courses do not further improve lung function and are associated with risks of adverse consequences. These risks principally include restricted intrauterine growth, altered brain development, postnatal insulin resistance and changes to the hypothalamic-pituitary-adrenal axis.
SUMMARY: The research challenges in this field are now centred on uncovering the mechanisms by which cortisol is involved in programming the fetus for its future metabolic life, and discovering ways in which the effectiveness and safety of antenatal glucocorticoids can be enhanced.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441700     DOI: 10.1097/00001703-200212000-00006

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  11 in total

1.  Giving steroids before elective caesarean section.

Authors:  Philip J Steer
Journal:  BMJ       Date:  2005-09-24

2.  Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle.

Authors:  Richard R Almon; Debra C Dubois; Jin Y Jin; William J Jusko
Journal:  J Endocrinol       Date:  2005-01       Impact factor: 4.286

Review 3.  The management of preterm labour.

Authors:  Jayanta Chatterjee; Joanna Gullam; Manu Vatish; Steve Thornton
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-03       Impact factor: 5.747

4.  Impact of preterm birth on the developing myocardium of the neonate.

Authors:  Jonathan G Bensley; Lynette Moore; Robert De Matteo; Richard Harding; Mary Jane Black
Journal:  Pediatr Res       Date:  2018-01-31       Impact factor: 3.756

5.  Repeated courses of antenatal corticosteroids have adverse effects on aspects of brain development in naturally delivered baboon infants.

Authors:  Amy Shields; Merran Thomson; Vicki Winter; Jacqueline Coalson; Sandra Rees
Journal:  Pediatr Res       Date:  2012-02-14       Impact factor: 3.756

6.  Antenatal dexamethasone treatment leads to changes in gene expression in a murine late placenta.

Authors:  B Baisden; S Sonne; R M Joshi; V Ganapathy; P S Shekhawat
Journal:  Placenta       Date:  2007-06-07       Impact factor: 3.481

7.  Effects of maternal treatment with corticosteroids on tight junction protein expression in the cerebral cortex of the ovine fetus with and without exposure to in utero brain ischemia.

Authors:  Shadi N Malaeb; Grazyna B Sadowska; Barbara S Stonestreet
Journal:  Brain Res       Date:  2007-06-02       Impact factor: 3.252

8.  Effects of maternal antenatal glucocorticoid treatment on apoptosis in the ovine fetal cerebral cortex.

Authors:  Shadi N Malaeb; Virginia Hovanesian; Matthew D Sarasin; Silvia M Hartmann; Grazyna B Sadowska; Barbara S Stonestreet
Journal:  J Neurosci Res       Date:  2009-01       Impact factor: 4.164

9.  A primate-specific RNA-binding protein (RBMXL3) is involved in glucocorticoid regulation of human pulmonary surfactant protein B (SP-B) mRNA stability.

Authors:  Lidan Liu; Xiangli Liu; Weizhen Bi; Joseph L Alcorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-03-10       Impact factor: 5.464

10.  Protective effects of indomethacin and dexamethasone in a goat model with intrauterine balloon aortic valvuloplasty.

Authors:  Kaiyu Zhou; Gang Wu; Yifei Li; Liang Zhao; Rong Zhou; Qi Zhu; Xupei Huang; Dezhi Mu; Yimin Hua
Journal:  J Biomed Sci       Date:  2012-08-13       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.